A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus

Phytomedicine

Volumn 14, Issue 7-8, 2007, Pages 437-446

  Chainani Wu, N ^a   Silverman Jr , S ^a   Reingold, A ^b   Bostrom, A ^c   Mc Culloch, C ^c   Lozada Nur, F ^a   Weintraub, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trial; Curcuminoids; Oral lichen planus; Turmeric

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CURCUMIN; CURCUMINOID DERIVATIVE; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; FLUCONAZOLE; PLACEBO; PREDNISONE; STEROID; TURMERIC; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AYURVEDA; BLOATING; CHRONIC DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURCUMA LONGA; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEARTBURN; HUMAN; INSOMNIA; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; MOUTH LICHEN PLANUS; NAUSEA; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOMATOLOGY; TRADITIONAL MEDICINE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CANDIDIASIS; CURCUMIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYTOTHERAPY; TREATMENT FAILURE;

CURCUMA LONGA;

EID: 34447563962     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.05.003     Document Type: Article

References (16)

1. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J. Altern. Complement. Med. 9 (2003) 161-168
2. Chainani-Wu N., Silverman Jr. S., Lozada-Nur F., Mayer P., et al. Oral lichen planus: patient profile, disease progression and treatment responses. J. Am. Dent. Assoc. 132 (2001) 901-909
3. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001) 2895-2900
4. Eigner D., and Scholz. Ferula asafoetida and Curcuma longa in traditional medical treatment and diet in Nepal. J. Ethnopharmacol. 67 (1999) 1-6
5. Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 88 (1999) 431-436
6. Lozada F., and Silverman Jr. S. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases. Arch. Dermatol. 116 (1980) 898-901
7. Lozada-Nur F., and Miranda C. Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin. Cutan. Med. Surg. 16 (1997) 273-277
8. Lozada-Nur F., Miranda C., and Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg. Oral Med. Oral Pathol. 77 (1994) 598-604
9. Majeed M., Badmaev V., and Frank M. Turmeric and the Healing Curcuminoids. A Keats Good Health Guide (1996), Keats Publishing, Inc, New Canaan, CT
10. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines (1999), The Stonesong Press, Inc
11. Porter S.R., Kirby A., Olsen I., and Barrett W. Immunologic aspects of dermal and oral lichen planus. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 83 (1997) 358-366
12. Rasyid A., and Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment. Pharmacol. Ther. 13 (1999) 245-249
13. Schubert M.M., Williams B.E., Lloid M.E., Donaldson G., et al. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 69 (1992) 2469-2477
14. Shah B.H., Nawaz Z., Pertani S.A., Roomi A., et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca21 signaling. Biochem. Pharmacol. 58 (1999) 1167-1172
15. Silverman Jr. S., Lozada-Nur F., and Migliorati C. Clinical efficiency of prednisone in the treatment of patients with oral inflammatory ulcerative diseases: a study of fifty-five patients. Oral Surg. Oral Med. Oral Pathol. 59 (1985) 360-363
16. Sugerman P.B., Savage N.W., Walsh L.J., and Seymour G.J. Disease mechanisms in oral lichen planus. A possible role for autoimmunity. Australas. J. Dermatol. 34 (1993) 63-69